A carregar...
The development of anticancer ruthenium(II) complexes: from single molecule compounds to nanomaterials
Cancer is rapidly becoming the top killer in the world. Most of the FDA approved anticancer drugs are organic molecules, while metallodrugs are very scarce. The advent of first metal based therapeutic agent, cisplatin, launched a new era in the application of transition metal complexes for therapeut...
Na minha lista:
| Publicado no: | Chem Soc Rev |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5624840/ https://ncbi.nlm.nih.gov/pubmed/28654103 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1039/c7cs00195a |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|